Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP335816.RAWCn0DXceoM311HFq3DuKoYplg3SZF5pFdoyFX4mChZo130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335816.RAWCn0DXceoM311HFq3DuKoYplg3SZF5pFdoyFX4mChZo130_provenance.
• NP371760.RAd-3VuXtPrJl23sGCkQBwK7PtFDAINcVhZGEXB4pAgbA130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371760.RAd-3VuXtPrJl23sGCkQBwK7PtFDAINcVhZGEXB4pAgbA130_provenance.
• NP536654.RAkxPMwm0_CtDs3Gjw6bKNIHfbbk0vFsBzyWLoxgaAzLs130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536654.RAkxPMwm0_CtDs3Gjw6bKNIHfbbk0vFsBzyWLoxgaAzLs130_provenance.
• NP848767.RAX5zGzErQAJrb-BJZufW1CTMbXZe8Cmz-faDKwZHYlis130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848767.RAX5zGzErQAJrb-BJZufW1CTMbXZe8Cmz-faDKwZHYlis130_provenance.
• assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP920697.RAJG6Gg6ibm_LL-lnE3ye-vygY5k4AcufTI9iCgJtPUEU130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920697.RAJG6Gg6ibm_LL-lnE3ye-vygY5k4AcufTI9iCgJtPUEU130_provenance.
• NP921527.RAMR5tJC7HTtEsIDzVJXf44qcLRUTpXxkwFjRym3sUncY130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921527.RAMR5tJC7HTtEsIDzVJXf44qcLRUTpXxkwFjRym3sUncY130_provenance.
• NP251701.RAReUYiDddCHxZzb7ov8xjxx4iqSwoFobODTm2PUw9TuQ130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251701.RAReUYiDddCHxZzb7ov8xjxx4iqSwoFobODTm2PUw9TuQ130_provenance.
• NP731531.RAUtl1ZTKckXdH9DbHuzba6d9zA8axiNLWvdEE1uy1PHw130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731531.RAUtl1ZTKckXdH9DbHuzba6d9zA8axiNLWvdEE1uy1PHw130_provenance.
• NP1382245.RAbhSZb69RSaQQK0m3x8jWWJSxbhrk2HOX8ZZK2N4235o130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1382245.RAbhSZb69RSaQQK0m3x8jWWJSxbhrk2HOX8ZZK2N4235o130_provenance.
• NP726749.RAEOZGv5LcoLsxRuhx6l0rjP4bVg0VxJj-_6AG8YnbkY8130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726749.RAEOZGv5LcoLsxRuhx6l0rjP4bVg0VxJj-_6AG8YnbkY8130_provenance.
• assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP726800.RAsY44Ml6PKLSZOCwlGqNzHlPV1WohvBUGkxp2-9o51SM130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726800.RAsY44Ml6PKLSZOCwlGqNzHlPV1WohvBUGkxp2-9o51SM130_provenance.
• NP1382244.RAFL0J1CQMsIO1C2bLqJKIfuotIwBQTaPIhRf503EC8tQ130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1382244.RAFL0J1CQMsIO1C2bLqJKIfuotIwBQTaPIhRf503EC8tQ130_provenance.
• NP1382243.RAnknEcYzmOym32IAta1gAkmZGC2ObsFQsl2a2hk6FQ8M130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1382243.RAnknEcYzmOym32IAta1gAkmZGC2ObsFQsl2a2hk6FQ8M130_provenance.
• NP1382246.RAn30_UNSmbZ42mkF30WTTe0Wgw_MzNLvgFLVGGKgAhtw130_assertion description "[We have demonstrated that anti-sense phosphorothioate oligodeoxynucleotides (AS S-oligos) directed against the EGF-like growth factors CRIPTO (CR), amphiregulin (AR) or transforming-growth-factor-alpha(TGFalpha) mRNA, are equipotent in their ability to inhibit the growth of human colon-carcinoma GEO cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1382246.RAn30_UNSmbZ42mkF30WTTe0Wgw_MzNLvgFLVGGKgAhtw130_provenance.